(3S,4S)-N-(cyanomethyl)-4-(morpholine-4-carbonyl)-1-(2-(trifluoromethyl)phenylsulfonyl)pyrrolidine-3-carboxamide

ID: ALA3093945

PubChem CID: 72793723

Max Phase: Preclinical

Molecular Formula: C19H21F3N4O5S

Molecular Weight: 474.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CCNC(=O)[C@@H]1CN(S(=O)(=O)c2ccccc2C(F)(F)F)C[C@H]1C(=O)N1CCOCC1

Standard InChI:  InChI=1S/C19H21F3N4O5S/c20-19(21,22)15-3-1-2-4-16(15)32(29,30)26-11-13(17(27)24-6-5-23)14(12-26)18(28)25-7-9-31-10-8-25/h1-4,13-14H,6-12H2,(H,24,27)/t13-,14-/m1/s1

Standard InChI Key:  WIJLWBKFRDYYLS-ZIAGYGMSSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
    3.4930  -21.8452    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6515  -22.6469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2665  -22.1088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7566  -21.0717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5370  -20.8293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5495  -20.0121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7733  -19.7483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2873  -20.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2174  -19.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5297  -18.9683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0834  -18.3673    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7323  -18.7893    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4896  -18.0045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6962  -17.8243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1391  -18.4227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3812  -19.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1803  -19.3874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9591  -19.8843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1436  -18.7274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6270  -19.4135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3687  -19.7565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1098  -20.0975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6913  -22.0037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1559  -21.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3549  -21.5450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0906  -22.3192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6335  -22.9356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4325  -22.7745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9731  -23.3873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7127  -24.1619    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.7741  -23.2255    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5494  -23.9627    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  1  3  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  6  9  1  6
  7 10  1  1
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  9 18  1  0
  9 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  3  0
  4  1  1  0
  1 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
M  END

Associated Targets(Human)

CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

A20 (109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 474.46Molecular Weight (Monoisotopic): 474.1185AlogP: 0.44#Rotatable Bonds: 5
Polar Surface Area: 119.81Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.23CX Basic pKa: CX LogP: -0.56CX LogD: -0.56
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.62Np Likeness Score: -1.86

References

1. Hilpert H, Mauser H, Humm R, Anselm L, Kuehne H, Hartmann G, Gruener S, Banner DW, Benz J, Gsell B, Kuglstatter A, Stihle M, Thoma R, Sanchez RA, Iding H, Wirz B, Haap W..  (2013)  Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.,  56  (23): [PMID:24224654] [10.1021/jm401528k]

Source